Your browser doesn't support javascript.
loading
A novel berberine-metformin hybrid compound exerts therapeutic effects on obese type 2 diabetic rats.
Jia, Dan; Li, Zi Wen; Zhou, Xinxin; Gao, Ying; Feng, Yifan; Ma, Min; Wu, Zhengzhi; Li, Weimin.
Affiliation
  • Jia D; Integrated Chinese and Western Medicine Post-doctoral Research Station, Jinan University, Guangzhou, China.
  • Li ZW; The First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital, Shenzhen, China.
  • Zhou X; Shenzhen Institute of Geriatrics, Shenzhen, China.
  • Gao Y; Shenzhen Institute of Geriatrics, Shenzhen, China.
  • Feng Y; Academy of Traditional Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou, China.
  • Ma M; Academy of Traditional Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou, China.
  • Wu Z; Central Laboratory of Guangdong Pharmaceutical University, GuangZhou, China.
  • Li W; Integrated Chinese and Western Medicine Post-doctoral Research Station, Jinan University, Guangzhou, China.
Clin Exp Pharmacol Physiol ; 46(6): 533-544, 2019 06.
Article in En | MEDLINE | ID: mdl-30883863
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Therapeutic Methods and Therapies TCIM: Plantas_medicinales Main subject: Berberine / Diabetes Mellitus, Type 2 / Hypoglycemic Agents / Metformin / Obesity Language: En Journal: Clin Exp Pharmacol Physiol Year: 2019 Type: Article Affiliation country: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Therapeutic Methods and Therapies TCIM: Plantas_medicinales Main subject: Berberine / Diabetes Mellitus, Type 2 / Hypoglycemic Agents / Metformin / Obesity Language: En Journal: Clin Exp Pharmacol Physiol Year: 2019 Type: Article Affiliation country: China